Dimensional Fund Advisors LP Adma Biologics, Inc. Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 4,860,314 shares of ADMA stock, worth $96.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,860,314

Previous 4,668,320 4.11%

Holding current value

$96.6 Million

Previous $80.1 Million 20.44%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$15.44 - $20.61 $2.96 Million - $3.96 Million	191,994 Added 4.11%	4,860,314 $96.4 Million
Q4 2024 Feb 13, 2025	BUY	$15.62 - $22.62 $10.1 Million - $14.6 Million	643,661 Added 15.99%	4,668,320 $80.1 Million
Q3 2024 Nov 07, 2024	BUY	$11.21 - $20.03 $9.72 Million - $17.4 Million	866,699 Added 27.44%	4,024,659 $80.5 Million
Q2 2024 Aug 09, 2024	SELL	$5.98 - $11.18 $2.63 Million - $4.92 Million	-440,076 Reduced 12.23%	3,157,960 $35.3 Million
Q1 2024 May 10, 2024	BUY	$4.4 - $6.74 $470,690 - $721,011	106,975 Added 3.06%	3,598,036 $23.7 Million
Q4 2023 Feb 07, 2024	BUY	$3.08 - $4.52 $1.73 Million - $2.54 Million	561,243 Added 19.16%	3,491,061 $15.8 Million
Q3 2023 Nov 09, 2023	BUY	$3.47 - $4.61 $5.73 Million - $7.61 Million	1,651,433 Added 129.18%	2,929,818 $10.5 Million
Q2 2023 Aug 09, 2023	BUY	$3.12 - $4.22 $3.82 Million - $5.16 Million	1,222,854 Added 2202.11%	1,278,385 $4.72 Million
Q4 2022 Feb 09, 2023	SELL	$2.47 - $3.88 $6,540 - $10,274	-2,648 Reduced 4.55%	55,531 $215,000
Q3 2022 Nov 10, 2022	SELL	$2.03 - $2.86 $11,739 - $16,539	-5,783 Reduced 9.04%	58,179 $141,000
Q2 2022 Aug 12, 2022	BUY	$1.43 - $2.2 $8,994 - $13,838	6,290 Added 10.91%	63,962 $126,000
Q4 2021 Feb 09, 2022	SELL	$1.09 - $1.66 $49,645 - $75,606	-45,546 Reduced 44.13%	57,672 $81,000
Q3 2021 Nov 12, 2021	SELL	$1.13 - $1.65 $40,787 - $59,556	-36,095 Reduced 25.91%	103,218 $117,000
Q2 2021 Aug 12, 2021	SELL	$1.51 - $2.07 $18,724 - $25,667	-12,400 Reduced 8.17%	139,313 $223,000
Q1 2021 May 14, 2021	BUY	$1.67 - $2.95 $253,360 - $447,553	151,713 New	151,713 $267,000

Others Institutions Holding ADMA

# of Institutions

379

Shares Held

188M

Call Options Held

2.53M

Put Options Held

696K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.9B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Adma Biologics, Inc. Transaction History